Facebook Forces Drug Companies To Open Their Walls
Pharmaceutical companies are losing a special privilege on Facebook today -- the ability to block public comments on a Facebook wall.
Pharmaceutical companies are losing a special privilege on Facebook today — the ability to block public comments on a Facebook wall.
Turns out, the heavily regulated nature of their industry, and penalties for marketing materials on the Internet, resulted in very constricted and tightly controlled Facebook pages and groups from drug companies.
(Our sister site, Inside Facebook, gives some valuable background on the issue by explaining why drug companies were slow to engage on social networks.)
To alleviate these concerns, Facebook enabled drug companies to close off their walls to comments and in some cases, disallow likes, bypassing the issue of having to respond to every complaint or censor unwanted posts.
It
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in